FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37061711000001109: Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
44901000001119 Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
44921000001114 Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Is a Sodium zirconium cyclosilicate 5g oral powder sachets true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Is a Lokelma true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Has specific active ingredient Sodium zirconium cyclosilicate false Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Has dispensed dose form Drug powder false Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Has dispensed dose form Powder true Inferred relationship Existential restriction modifier
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Has specific active ingredient Sodium zirconium cyclosilicate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) 30 sachet Has AMP True Lokelma 5g oral powder sachets (AstraZeneca UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start